EUVIMEDObjevte EUVIMED
Crossref

BCKDHA contributes to melanoma progression by promoting the expressions of lipogenic enzymes FASN and ACLY

Yangzi Tian iD, Jingjing Ma, Mengru Wang, Xiuli Yi, Sen Guo, Hao Wang, Hengxiang Zhang, Huina Wang, Yuqi Yang, Baolu Zhang, Juan Du, Qiong Shi and 3 more

Experimental Dermatology · 2023

DOI: 10.1111/exd.14865 ↗

At a glance

Journal article in Experimental Dermatology, 2023. Written by Yangzi Tian and 14 co-authors. Institution: Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, China. Major MEDLINE topics: ATP Citrate (pro-S)-Lyase, Melanoma. Cited 8 times so far (Crossref); 23 references. Funded by: National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The dysregulation of branched‐chain amino acid (BCAA) metabolism and related enzymes has been greatly implicated in the progression of multiple types of cancer, whereas remains far from understood in melanoma. Here, we explored the role of the BCAA metabolism enzyme BCKDHA in melanoma pathogenesis and elucidated the underlying mechanisms. In vitro cell biology experiments and in vivo pre‐clinical mice model experiments were performed to investigate the role of BCKDHA in melanoma progression. RNA sequencing, immunohistochemical/immunofluorescence staining and bioinformatics analysis were used to examine the underlying mechanism. BCKDHA expression was prominently increased in both melanoma tissues and cell lines. The up‐regulation of BCKDHA promoted long‐term tumour cell proliferation, invasion and migration in vitro and tumour growth in vivo. Through RNA‐sequencing technology, it was found that BCKDHA regulated the expressions of lipogenic fatty acid synthase (FASN) and ATP‐citrate lyase (ACLY), which was thereafter proved to mediate the oncogenic role of BCKDHA in melanoma. Our results demonstrate that BCKDHA promotes melanoma progression by regulating FASN and ACLY expressions. Targeting BCKDHA could be exploited as a promising strategy to restrain tumour progression in melanoma.

Subjects

MeSH terms (MEDLINE)

ATP Citrate (pro-S)-LyaseMelanomaAnimalsMiceCell LineCell ProliferationLipogenesisFatty Acid Synthase, Type I

Author keywords

ACLYBCKDHAFASNlipogenesismelanoma

Substances

ATP Citrate (pro-S)-LyaseFasn protein, mouseFatty Acid Synthase, Type I

Authors and institutions

  • Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

ORCID profiles: Yangzi Tian

Funding

  • National Natural Science Foundation of China

Cite

APA

Tian, Y., Ma, J., Wang, M., Yi, X., Guo, S., Wang, H., Zhang, H., Wang, H., Yang, Y., Zhang, B., Du, J., Shi, Q., Gao, T., Li, C., & Guo, W. (2023). BCKDHA contributes to melanoma progression by promoting the expressions of lipogenic enzymes FASN and ACLY. Experimental Dermatology. https://doi.org/10.1111/exd.14865

Vancouver

Tian Y, Ma J, Wang M, Yi X, Guo S, Wang H, et al. BCKDHA contributes to melanoma progression by promoting the expressions of lipogenic enzymes FASN and ACLY. Experimental Dermatology. 2023. doi:10.1111/exd.14865

BibTeX
@article{Tian2023,
  author = {Tian, Yangzi and Ma, Jingjing and Wang, Mengru and Yi, Xiuli and Guo, Sen and Wang, Hao and Zhang, Hengxiang and Wang, Huina and Yang, Yuqi and Zhang, Baolu and Du, Juan and Shi, Qiong and Gao, Tianwen and Li, Chunying and Guo, Weinan},
  title = {BCKDHA contributes to melanoma progression by promoting the expressions of lipogenic enzymes FASN and ACLY},
  journal = {Experimental Dermatology},
  year = {2023},
  doi = {10.1111/exd.14865}
}
Start for free →